The Fertility Clinic, Rigshospitalet - University Hospital of Copenhagen, Copenhagen, Denmark,
J Assist Reprod Genet. 2012 Jun;29(6):473-7. doi: 10.1007/s10815-012-9787-x. Epub 2012 May 6.
This guideline aims to serve as a reference for fertility specialists and other specialists working with young patients at risk of premature ovarian insufficiency (POI) or testicular dysfunction (TD) due to treatment of Hodgkin or Non-Hodgkin lymphoma.
PubMed search of articles addressing risk of POI and TD according to different treatment protocols used in lymphoma patients. PubMed search of articles presenting different options for fertility treatment in cancer patients.
The risk of POI/TD depends on the protocol used with the highest risk in patients treated with haematopoietic stem cell transplantation/bone marrow transplantation (HSCT/BMT) and the lowest risk in patients treated with ABVD (Adriamycin, Bleomycin, Vincristine and Decarbazine). The different options of fertility preservation are discussed and their relevance according to treatment protocol, age of the patient and urgency to start treatment.
Fertility issues should be discussed with all women of fertile age. Fertility preservation should be offered to young women when relevant. Children should be informed together with their parents. All men should be offered semen cryopreservation regardless of protocol used. At present, there are no established methods of fertility preservation in pre-pubertal boys. This guideline offers suggestions to the most preferred methods of fertility preservation according to treatment protocol, age of the patient, and urgency to start treatment.
本指南旨在为生育专家和其他治疗霍奇金或非霍奇金淋巴瘤的年轻患者发生卵巢早衰(POI)或睾丸功能障碍(TD)风险的专家提供参考。
在 PubMed 上搜索针对不同淋巴瘤患者治疗方案导致 POI 和 TD 风险的文章。在 PubMed 上搜索针对癌症患者生育治疗不同选择的文章。
POI/TD 的风险取决于所使用的方案,造血干细胞移植/骨髓移植(HSCT/BMT)患者的风险最高,ABVD(阿霉素、博来霉素、长春新碱和达卡巴嗪)患者的风险最低。讨论了不同的生育保存选择,并根据治疗方案、患者年龄和开始治疗的紧迫性讨论了其相关性。
应与所有育龄妇女讨论生育问题。当相关时,应向年轻女性提供生育保存。应与父母一起告知儿童。无论使用何种方案,都应向所有男性提供精子冷冻保存。目前,青春期前男孩尚无既定的生育保存方法。本指南根据治疗方案、患者年龄和开始治疗的紧迫性,为生育保存的最优选方法提供了建议。